Long-term outcome of catheter ablation for atrial fibrillation in patients with severe left atrial enlargement and reduced left ventricular ejection fraction.
Andrea DemarchiLaura NeumannRoberto RordorfGiulio ConteAntonio SanzoTardu ÖzkartalSimone SavastanoFrançois RegoliAlessandro VicentiniMaria Luce CaputoCatherine KlersyBarbara PetracciFlavia PiciacchiaJolie BrunoEnrico BaldiSabatino D'AmoreAngelo AuricchioPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2022)
The long-term outcome of patients with severe LA dilatation and reduced LVEF is comparable to those with severe LA enlargement but preserved LVEF. Long-term efficacy of PVI is certainly affected by the enlargement of the left atrium, but less so by the addition of a reduced LVEF. CA remains the best strategy for rhythm control both in paroxysmal and persistent AF in this subgroup of patients.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- ejection fraction
- aortic stenosis
- left atrial appendage
- oral anticoagulants
- left ventricular
- heart failure
- direct oral anticoagulants
- early onset
- newly diagnosed
- end stage renal disease
- prognostic factors
- chronic kidney disease
- randomized controlled trial
- percutaneous coronary intervention
- mitral valve
- acute myocardial infarction
- drug induced
- coronary artery disease
- blood pressure
- vena cava
- inferior vena cava
- clinical trial
- pulmonary embolism